Skyward Specialty Insurance Group (SKWD) is back in focus after its second quarter 2026 report showed higher revenue, increased earnings per share, and a completed share repurchase. Together, these factors are reshaping how some investors view the stock.

The recent quarterly update, completion of the US$9.7 million buyback, and the earlier Apollo Group Holdings acquisition have contributed to a strong run for Skyward Specialty Insurance Group, with a 90 day share price return of 38.9% and a 3 year total shareholder return of 156.63%. This comes even after a 1 day share price decline of 2.99% left the stock at US$63.67.

If this kind of momentum has your attention, it can be useful to broaden your search beyond a single stock. Take a look at 19 top founder-led companies

Skyward Specialty Insurance Group is clearly executing as a business after its recent results and acquisition move, and the share price has moved with it. The next step is to test whether that recent enthusiasm still leaves value on the table.

Most Popular Narrative: 4.5% Undervalued

At a last close of $63.67 against a narrative fair value of about $66.64, Skyward Specialty Insurance Group is framed as slightly undervalued, with that view resting heavily on how it uses technology and specialty focus to shape future profits.

Ongoing expansion of digital risks, including cyber exposures linked to digital transformation across industries, and the company's investment in proprietary platforms (like SkyVantage) and early adoption of AI are positioning Skyward to capture emerging opportunities with new specialty products, aiding future revenue growth and margin expansion.

Want to see what this narrative is really baking in? The story leans on compounding revenue, firmer margins and a richer future earnings multiple. Curious which assumptions do the heavy lifting.

At the core is a discount rate of 7.24% and a view that Skyward Specialty Insurance Group can grow earnings and revenue at a pace that supports a higher valuation multiple than many insurance peers, while still keeping its specialty focus intact. The fair value also reflects analyst expectations about how much profit each dollar of revenue could produce several years from now and what investors might be willing to pay for those earnings in the future.

Result: Fair Value of $66.64 (UNDERVALUED)

However, you still need to weigh risks such as softer commercial pricing and concentrated MGA partnerships, which could pressure Skyward Specialty Insurance Group's margins and overall growth prospects.

Another View On Skyward Specialty Insurance Group's Valuation

The narrative fair value for Skyward Specialty Insurance Group points to a 4.5% gap, yet the P/E picture looks very different. SKWD trades on a 15x P/E compared with 9.2x for peers, 11.6x for the US Insurance industry and a fair ratio estimate of 14.7x. That richer multiple may reflect quality, or it may leave less room for error if growth or margins fall short.

To see what the numbers say about this price, review the valuation breakdown in more detail via See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With both risks and rewards on the table for Skyward Specialty Insurance Group, it makes sense to review the numbers yourself and decide quickly how you feel. To see the mix of potential upsides and concerns in one place, start with 3 key rewards and 1 important warning sign

Looking For More Investment Ideas Beyond Skyward Specialty Insurance Group?

If Skyward Specialty Insurance Group has sharpened your focus, now is the time to scan for other opportunities before the next wave of moves passes you by.

• Target resilient payouts by reviewing companies with strong yields and stability through the 8 dividend fortresses.
• Spot potential mispricings early and compare them with Skyward Specialty Insurance Group using the 52 high quality undervalued stocks.
• Zero in on robustness and financial strength so your watchlist leans toward durable businesses with the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.